| CL1844A |
|
253128-41-5 |
艾日布林
Eribulin | B1939 | E7389 | ER-086526
-
98+%
|
需詢價(jià) |
C40H59NO11 |
|
|
|
| CL1869 |
|
908112-43-6 |
SNX 2112 | PF-04928473
SNX 2112 | PF-04928473
3-5days
98+%
|
￥668.00 |
C23H27F3N4O3 |
|
|
|
| CL2903B |
|
142373-60-2 |
鹽酸替羅非班 | 鹽酸替洛非巴
Tirofiban hydrochloride | L700462 hydrochloride | MK383 hydrochloride)
-
98+%
|
需詢價(jià) |
C22H37ClN2O5S |
|
|
|
| CL2903A |
|
144494-65-5 |
替羅非班 | L700462 | MK383
Tirofiban | L700462 | MK383
-
98+%
|
需詢價(jià) |
C22H36N2O5S |
|
|
|
| CL2903 |
|
150915-40-5 |
鹽酸替羅非班一水合物
Tirofiban Hydrochloride monohydrate | Tirofiban HCl | L700462 hydrochloride monohydrate | MK383 hydrochloride monohydrate
-
98+%
|
需詢價(jià) |
C22H39ClN2O6S |
|
|
|
| CL2890 |
|
1228445-38-2 |
N-(環(huán)丙基甲基)-4-((4-(6-羥基-3,4-二氫喹啉-1(2H)-基)嘧啶-2-基)氨基)苯磺酰胺
Pyrintegrin | PTN | N-(Cyclopropylmethyl)-4-((4-(6-hydroxy-3,4-dihydroquinolin-1(2H)-yl)pyrimidin-2-yl)amino)benzenesulfonamide
3-5days
98+%
|
￥668.00 |
C23H25N5O3S |
|
|
|
| CL2726 |
|
796073-69-3 |
|
需詢價(jià) |
C38H54ClN3O10S |
|
|
|
| CL2644 |
|
1642288-47-8 |
瑪伐凱泰 | 馬瓦卡坦
Mavacamten (MYK-461)
-
98+%
|
需詢價(jià) |
C15H19N3O2 |
|
|
|
| CL1348A |
|
1415246-68-2 |
MMAF hydrochloride
MMAF Hydrochloride;Monomethylauristatin F Hydrochloride
3-5days
98+%
|
￥800.00 |
C39H66ClN5O8 |
|
|
|
| CL2467 |
|
1025967-78-5 |
立他司特
Lifitegrast; SAR 1118
3-5days
98+%
|
￥500.00 |
C29H24Cl2N2O7S |
|
|
|
| CLA1358 |
|
1342290-43-0 |
阿利魯單抗
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1352 |
|
1105038-73-0 |
阿比妥珠單抗
Abituzumab (Anti-Integrin aV / ITGAV / CD51)
3-5days
95+%
|
￥2800.00 |
— |
|
|
|
| CLA1265 |
|
1044758-60-2 |
依曲利組單抗
Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)
3-5days
95+%
|
￥6200.00 |
— |
|
|
|
| CLA1226 |
|
339086-79-2 |
羅維珠單抗
Rovelizumab
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1211 |
|
211323-03-4 |
厄利珠單抗
Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
3-5days
95+%
|
￥5500.00 |
— |
|
|
|
| CLA1196 |
|
558480-40-3 |
伏洛昔單抗
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1185 |
|
892553-42-3 |
埃達(dá)組單抗
Etaracizumab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1118 |
|
143653-53-6 |
阿昔單抗
Abciximab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1108 |
|
159445-64-4 |
奧度莫單抗
Odulimomab
3-5days
95+%
|
￥6000.00 |
— |
|
|
|
| CLA1097 |
|
142864-19-5 |
恩莫單抗
Enlimomab
3-5days
95+%
|
￥5200.00 |
— |
|
|
|
